Cargando…

Chronic inflammation and asthma

Allergic asthma is a complex and chronic inflammatory disorder which is associated with airway hyper-responsiveness and tissue remodelling of the airway structure. Although originally thought to be a Th2-driven inflammatory response to inhaled innocuous allergen, the immune response in asthma is now...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdoch, Jenna R., Lloyd, Clare M.
Formato: Texto
Lenguaje:English
Publicado: Elsevier 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923754/
https://www.ncbi.nlm.nih.gov/pubmed/19769993
http://dx.doi.org/10.1016/j.mrfmmm.2009.09.005
_version_ 1782185539609296896
author Murdoch, Jenna R.
Lloyd, Clare M.
author_facet Murdoch, Jenna R.
Lloyd, Clare M.
author_sort Murdoch, Jenna R.
collection PubMed
description Allergic asthma is a complex and chronic inflammatory disorder which is associated with airway hyper-responsiveness and tissue remodelling of the airway structure. Although originally thought to be a Th2-driven inflammatory response to inhaled innocuous allergen, the immune response in asthma is now considered highly heterogeneous. There are now various in vivo systems which have been designed to examine the pathways leading to the development of this chronic immune response and reflect, in part this heterogeneity. Furthermore, the emergence of endogenous immunoregulatory pathways and active pro-resolving mediators hold great potential for future therapeutic intervention. In this review, the key cellular and molecular mediators relating to chronic allergic airway disease are discussed, as well as emerging players in the regulation of chronic allergic inflammation.
format Text
id pubmed-2923754
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-29237542010-09-08 Chronic inflammation and asthma Murdoch, Jenna R. Lloyd, Clare M. Mutat Res Review Allergic asthma is a complex and chronic inflammatory disorder which is associated with airway hyper-responsiveness and tissue remodelling of the airway structure. Although originally thought to be a Th2-driven inflammatory response to inhaled innocuous allergen, the immune response in asthma is now considered highly heterogeneous. There are now various in vivo systems which have been designed to examine the pathways leading to the development of this chronic immune response and reflect, in part this heterogeneity. Furthermore, the emergence of endogenous immunoregulatory pathways and active pro-resolving mediators hold great potential for future therapeutic intervention. In this review, the key cellular and molecular mediators relating to chronic allergic airway disease are discussed, as well as emerging players in the regulation of chronic allergic inflammation. Elsevier 2010-08-07 /pmc/articles/PMC2923754/ /pubmed/19769993 http://dx.doi.org/10.1016/j.mrfmmm.2009.09.005 Text en © 2010 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Review
Murdoch, Jenna R.
Lloyd, Clare M.
Chronic inflammation and asthma
title Chronic inflammation and asthma
title_full Chronic inflammation and asthma
title_fullStr Chronic inflammation and asthma
title_full_unstemmed Chronic inflammation and asthma
title_short Chronic inflammation and asthma
title_sort chronic inflammation and asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923754/
https://www.ncbi.nlm.nih.gov/pubmed/19769993
http://dx.doi.org/10.1016/j.mrfmmm.2009.09.005
work_keys_str_mv AT murdochjennar chronicinflammationandasthma
AT lloydclarem chronicinflammationandasthma